XML 35 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Financial Instruments
9 Months Ended
Sep. 30, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Financial Instruments

Note 12 – Financial Instruments

Cash, cash equivalents and restricted cash

The Company has cash that is legally restricted as to use or withdrawal. A reconciliation of cash and cash equivalents on the consolidated condensed balance sheets to cash, cash equivalents and restricted cash presented on the consolidated condensed statements of cash flows is as follows:

 

 

 

September 30,

2019

 

 

December 31,

2018

 

 

September 30,

2018

 

 

December 31,

2017

 

Cash and cash equivalents presented in the consolidated

   condensed balance sheets

 

$

45,200

 

 

$

39,620

 

 

$

47,152

 

 

$

103,172

 

Restricted cash

 

 

2,504

 

 

 

 

 

 

 

 

 

 

Cash, cash equivalents and restricted cash presented in the

   consolidated condensed statements of cash flows

 

$

47,704

 

 

$

39,620

 

 

$

47,152

 

 

$

103,172

 

 

Derivative Financial Instruments

We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $25,210 and $33,250 outstanding as of September 30, 2019 and December 31, 2018, respectively.  

The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years. No commodity swap contracts were outstanding at September 30, 2019 or at December 31, 2018.

We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated balance sheet.  When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk.  We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated statements of income. See Note 14 for the amount of unrealized loss associated with foreign currency derivatives previously reported in accumulated other comprehensive loss that was reclassified into earnings during 2019. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of September 30, 2019 is as follows:  

 

 

 

 

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

 

 

 

 

 

Hedge

Designation

 

Fair Value

Hierarchy

 

Balance Sheet

Location

 

Fair

Value

 

 

Balance Sheet

Location

 

Fair

Value

 

 

Net Asset/

(Liabilities)

 

Foreign currency derivatives

 

Cash flow hedge

 

Level 2

 

Current assets

 

$

897

 

 

Current liabilities

 

$

 

 

$

897

 

 

Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:  

 

 

 

Location

 

Three Months Ended September 30, 2019

 

 

Three Months Ended September 30, 2018

 

 

Nine Months Ended September 30, 2019

 

 

Nine Months Ended September 30, 2018

 

Foreign currency derivatives

 

Cost of sales

 

$

328

 

 

$

391

 

 

$

1,003

 

 

$

(214

)

 

 

Selling, general and administrative

 

 

 

 

 

 

 

 

 

 

 

75

 

 

 

Other comprehensive income

 

 

(257

)

 

 

1,753

 

 

 

806

 

 

 

2,304

 

 

 

Foreign currency gain (loss)

 

 

18

 

 

 

11

 

 

 

(51

)

 

 

58

 

Total foreign currency derivatives

 

 

 

$

89

 

 

$

2,155

 

 

$

1,758

 

 

$

2,223

 

Commodity derivatives

 

Cost of sales

 

$

 

 

$

 

 

$

 

 

$

145

 

 

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

$

(218

)

Total commodity derivatives

 

 

 

$

 

 

$

 

 

$

 

 

$

(73

)

 

We did not incur any hedge ineffectiveness during the three and nine months ended September 30, 2019 and 2018.